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each chapter has been written by a different author, one gets many
different perspectives. As access to human ES cell lines becomes
more wide spread, this field will rapidly move forward and in a
very short span of time this book will become outdated. However,
this still remains the most comprehensive review of all aspects of
the hES cell biology, and is a must for anyone planning to break
into the field.
M Clements
Wellcome Trust Research Fellow, University College London, UK
Ovarian cancer – American cancer society atlas of clinical
oncology
RF Ozols (Editor)
BC Decker. 2002. ISBN: 1-55009-096-8 d65.00
British Journal of Cancer (2004) 90, 559. doi:10.1038/sj.bjc.6601435 www.bjcancer.com
& 2004 Cancer Research UK
             
This multiauthor book on Ovarian Cancer edited by Ozols is a new
addition to the American Cancer Society Atlas of Clinical Oncology
series. As the name suggests, pictures and graphic illustrations are
prominent and it is this that sets the book apart from other
textbooks on ovarian cancer. The first two chapters on pathology
and biology use this technique well with numerous clear
illustrations of gross pathology and photomicrographs. The text
is reasonably comprehensive, although the pathology section
lacked information on the pattern of cytokeratin staining which
is frequently used to help distinguish ovarian cancers from other
malignant epithelial tumours involving the ovary. There is a strong
section on genetics that is well illustrated. However, in some
sections of the book the quality of graphic reproduction is poor.
There is a section on screening and counselling, but it did not
include ongoing screening research trials. There are generously
illustrated chapters on staging and surgical cytoreduction with a
text focusing on staging modalities and some of the controversies
surrounding the role of surgery.
Much of the second half of the book is devoted to therapy.
Chemotherapy is divided into chapters on primary chemotherapy,
developmental chemotherapy, including drug treatments at
relapse, and a chapter on high-dose chemotherapy. Recently
conducted clinical trials are discussed. References are reasonably
up to date, although some references to abstracts presented at the
American Society of Clinical Oncology meetings have now been
published as final papers. A whole chapter is devoted to high-dose
chemotherapy that is now only a relatively small component of
developmental chemotherapy. Also, the chapter refers almost
exclusively to the North American literature, with little mention of
the European data. The chapter on radiation therapy is very
detailed but clearly written. It provides a good reference to the field
but its emphasis in the book is rather greater than necessary;
nowadays radiation is used rather less frequently for the treatment
of ovarian cancer. Early stage management and palliative surgery
are two clinical areas dealt with in separate chapters. In the former,
the table of FIGO staging found in the chapter on staging is
repeated, which illustrates some of the difficulties in coordinating
a multiauthor text. Biological therapies are likely to become an
increasingly important component of ovarian cancer therapy and
the chapter on this is well written and illustrated. However, the
chief omission is any reference to inhibitors of EGFR or
angiogenesis. It is a pity that the chapters on germ cell and sex-
cord tumours appear as a ‘bolt on’. They are somewhat incomplete,
covering pathology and surgery with virtually nothing on
chemotherapeutic management.
The book is supplied with a CD Rom with full text and
illustrations (which is a little clumsy to run on an Apple
Macintosh). It is a useful accompaniment to the book that is
written from a North American perspective drawing mainly on the
writing of the world-renowned Fox Chase Cancer Centre, which
has extensive experience in the diagnosis and treatment of ovarian
cancer. The book is one of many on ovarian cancer. The main
criticism is that in some areas it falls in between a comprehensive
text and illustrated review. It will appeal mainly to a North
American readership and it is a useful addition to the library of
any clinical gynaecological oncologist.
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